BIOS Capital Management LP Invests $78.75 Million in Actuate Therapeutics (NASDAQ:ACTU)
BIOS Capital Management LP acquired a new position in Actuate Therapeutics (NASDAQ:ACTU – Free Report) during the fourth quarter, HoldingsChannel reports. The firm acquired 9,893,651 shares of the company’s stock, valued at approximately $78,753,000. Actuate Therapeutics accounts for 83.7% of BIOS Capital Management LP’s holdings, making the stock its biggest position. BIOS Capital Management LP […]
BIOS Capital Management LP acquired a new position in Actuate Therapeutics (NASDAQ:ACTU – Free Report) during the fourth quarter, HoldingsChannel reports. The firm acquired 9,893,651 shares of the company’s stock, valued at approximately $78,753,000. Actuate Therapeutics accounts for 83.7% of BIOS Capital Management LP’s holdings, making the stock its biggest position. BIOS Capital Management LP […]
